BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11899786)

  • 21. Induced costs of low-cost screening mammography.
    Cyrlak D
    Radiology; 1988 Sep; 168(3):661-3. PubMed ID: 3406395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer-aided detection of breast cancer: a cost-effectiveness study.
    Lindfors KK; McGahan MC; Rosenquist CJ; Hurlock GS
    Radiology; 2006 Jun; 239(3):710-7. PubMed ID: 16569787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An academic health center cost analysis of screening mammography: creating a financially viable service.
    Chen SL; Clark S; Pierce LJ; Hayes DF; Helvie MA; Greeno PL; Newman LA; Chang AE
    Cancer; 2004 Sep; 101(5):1043-50. PubMed ID: 15329914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost-effectiveness comparison of three tailored interventions to increase mammography screening.
    Saywell RM; Champion VL; Skinner CS; Menon U; Daggy J
    J Womens Health (Larchmt); 2004 Oct; 13(8):909-18. PubMed ID: 15671706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regarding trends in recall, biopsy, and positive biopsy rates for screening mammography.
    Ellis RL
    Radiology; 2006 Jan; 238(1):375-6; author reply 376. PubMed ID: 16373783
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-cost mass screening with mammography as a means of reducing overall mortality from breast cancer.
    McLelland R
    Radiol Clin North Am; 1987 Sep; 25(5):1007-13. PubMed ID: 3306771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in recall, biopsy, and positive biopsy rates for screening mammography in an academic practice.
    Gur D; Wallace LP; Klym AH; Hardesty LA; Abrams GS; Shah R; Sumkin JH
    Radiology; 2005 May; 235(2):396-401. PubMed ID: 15770039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality-oriented mass mammography screening.
    Burhenne LJ; Burhenne HJ; Kan L
    Radiology; 1995 Jan; 194(1):185-8. PubMed ID: 7997549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The British Columbia Mammography Screening Program: evaluation of the first 15 months.
    Burhenne LJ; Hislop TG; Burhenne HJ
    AJR Am J Roentgenol; 1992 Jan; 158(1):45-9. PubMed ID: 1307850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
    Allen MW; Hendi P; Schwimmer J; Bassett L; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):168-85. PubMed ID: 10967626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of breast cancer screening in Spain.
    Plans P; Casademont L; Salleras L
    Int J Technol Assess Health Care; 1996; 12(1):146-50. PubMed ID: 8690555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of mammographic screening strategies.
    Lindfors KK; Rosenquist CJ
    JAMA; 1995 Sep; 274(11):881-4. PubMed ID: 7674501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines.
    Lantz PM; Ubel PA
    J Gen Intern Med; 2005 Jun; 20(6):552-3. PubMed ID: 15987335
    [No Abstract]   [Full Text] [Related]  

  • 36. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
    Warmerdam PG; de Koning HJ; Boer R; Beemsterboer PM; Dierks ML; Swart E; Robra BP
    J Epidemiol Community Health; 1997 Apr; 51(2):180-6. PubMed ID: 9196649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammography utilization, public health impact, and cost-effectiveness in the United States.
    White E; Urban N; Taylor V
    Annu Rev Public Health; 1993; 14():605-33. PubMed ID: 8323604
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.